Claudia Martorell

2.4k total citations · 1 hit paper
28 papers, 1.3k citations indexed

About

Claudia Martorell is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Claudia Martorell has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Claudia Martorell's work include Hepatitis C virus research (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (6 papers). Claudia Martorell is often cited by papers focused on Hepatitis C virus research (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (6 papers). Claudia Martorell collaborates with scholars based in United States, France and United Kingdom. Claudia Martorell's co-authors include Timothy Eley, Fiona McPhee, Robert Reindollar, Dessislava I. Dimitrova, Anna S. Lok, Megan Wind‐Rotolo, Eric Lawitz, Vinod K. Rustgi, Dennis M. Grasela and David Gardiner and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Claudia Martorell

27 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

2012 454 citations Anna S. Lok, David Gardiner et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Claudia Martorell

Since Specialization

Citations

This map shows the geographic impact of Claudia Martorell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Martorell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Martorell more than expected).

Fields of papers citing papers by Claudia Martorell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Martorell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Martorell. The network helps show where Claudia Martorell may publish in the future.

Co-authorship network of co-authors of Claudia Martorell

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Martorell. A scholar is included among the top collaborators of Claudia Martorell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Martorell. Claudia Martorell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy 2024 ·AIDS ·Chloe Orkin, Andrea Antinori, Jürgen K. Rockstroh, Santiago Moreno, Claudia Martorell, Jean‐Michel Molina, Adriano Lazzarin, Franco Maggiolo, Yazdan Yazdanpanah, Kristen Andreatta, Hailin Huang, Jason T. Hindman, Hal Martin, Anton Pozniak	5
2	Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients 2019 ·SHILAP Revista de lepidopterología ·Olga Delgado Sánchez, Antonio Gutiérrez, (unknown), (unknown), Claudia Martorell, (unknown), Leyre Bento, Marta García‐Recio, Antònia Sampol	1
3	Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial 2019 ·The Lancet HIV ·Hans‐Jürgen Stellbrink, José Ramón Arribas, Jeffrey L. Stephens, Helmut Albrecht, Paul E. Sax, Franco Maggiolo, Catherine Creticos, Claudia Martorell, Xuelian Wei, Rima Acosta, Sean E Collins, Diana M. Brainard, Hal Martin	99
4	Clinical and immunological profile of children aged 5–9 years with persistent egg allergy before oral immunotherapy with egg. A multicenter, randomized controlled trial of the Spanish Society of Pediatric Allergy, Asthma and Clinical Immunology (SEICAP) 2018 ·Allergologia et Immunopathologia ·Luis Eduardo Echeverría, M.F. Martín‐Muñoz, Claudia Martorell, (unknown), (unknown), (unknown), (unknown), (unknown), Ana María Plaza, Candelaria Muñoz, Antonio Martorell, Cristina Blasco, (unknown), Catalina Gómez, Santiago Nevot, (unknown), Rosário Madero	1
5	Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96‐week results from two randomized clinical trials 2018 ·HIV Medicine ·(unknown), Chloe Orkin, (unknown), Anthony Mills, Cynthia Brinson, E DeJesus, Frank A. Post, (unknown), Melanie Thompson, Olayemi Osiyemi, Bruce Rashbaum, (unknown), Claudia Martorell, (unknown), (unknown), Danielle Porter, (unknown), Devi SenGupta, Manika Das	42
6	Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study 2017 ·The Lancet HIV ·Edwin DeJesus, Moti Ramgopal, Gordon Crofoot, Peter Ruane, Anthony LaMarca, Anthony Mills, Claudia Martorell, (unknown), Hans‐Jürgen Stellbrink, Jean‐Michel Molina, Frank A. Post, Ignacio Valero, Danielle Porter, Ya-Pei Liu, Andrew Cheng, Erin Quirk, Devi SenGupta, Huyen Cao	37
7	Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C 2014 ·Journal of Hepatology ·Jean–Pierre Bronowicki, Vlad Ratziu, Adrián Gadano, Paul J. Thuluvath, Fernando Bessone, Claudia Martorell, Stanislas Pol, Rubén Terg, Ziad Younes, Bing He, Timothy Eley, David Cohen, Fei Yu, Dennis Hernandez, Fiona McPhee, Patricia Méndez, Eric Hughes	21
8	Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor 2014 ·Journal of the International AIDS Society ·Martin Fisher, Cheryl McDonald, Graeme Moyle, Claudia Martorell, Moti Ramgopal, François Laplante, Joanne Curley, Hiba Graham, (unknown), Yapei Liu, Martin S. Rhee, Javier Szwarcberg	9
9	Cobicistat-Boosted Protease Inhibitors in HIV-Infected Patients with Mild to Moderate Renal Impairment 2014 ·HIV Clinical Trials ·Cheryl McDonald, Claudia Martorell, Moti Ramgopal, François Laplante, Martin Fisher, Frank A. Post, Yapei Liu, Joanne Curley, Michael E. Abram, Joseph M. Custodio, Hiba Graham, Martin S. Rhee, Javier Szwarcberg	12
10	1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 OR -4 CHRONIC HEPATITIS C: SVR24 RESULTS FROM A RANDOMIZED PHASE 2B STUDY (AI447016) 2013 ·Journal of Hepatology ·J.‐P. Bronowicki, Vlad Ratziu, Adrián Gadano, Paul J. Thuluvath, Fernando Bessone, Claudia Martorell, Stanislas Pol, Rubén Terg, Ziad Younes, Bing He, Timothy Eley, David Cohen, Patricia Méndez, Eric Hughes	10
11	Basophil activation test is a useful tool in occupational asthma due to iroko wood. 2013 ·PubMed ·(unknown), Claudia Martorell, Antonio Martorell, (unknown), (unknown), (unknown), M L Sánz	6
12	Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 breakdown → 2012 ·New England Journal of Medicine ·Anna S. Lok, David Gardiner, Eric Lawitz, Claudia Martorell, Gregory T. Everson, Reem Ghalib, Robert Reindollar, Vinod K. Rustgi, Fiona McPhee, Megan Wind‐Rotolo, Anna Persson, (unknown), Dessislava I. Dimitrova, Timothy Eley, Tong Guo, Dennis M. Grasela, C Pasquinelli	454
13	Effects of Darunavir/Ritonavir-Based Therapy on Metabolic and Anthropometric Parameters in Women and Men Over 48 Weeks 2011 ·AIDS Patient Care and STDs ·Judith S. Currier, Claudia Martorell, Olayemi Osiyemi, Michael T. Yin, Robert J. Ryan, Guy De La Rosa, Joseph Mrus	11
14	2005 VIROLOGIC RESPONSE RATES FOLLOWING 4 WEEKS OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONICALLY-INFECTED HCV GENOTYPE-1 PATIENTS 2010 ·Journal of Hepatology ·Ira M. Jacobson, Paul J. Pockros, Jacob Lalezari, E. Läwitz, M. Rodríguez‐Torres, E DeJesus, Felix Haas, Claudia Martorell, (unknown), Vivek S. Purohit, Subasree Srinivasan, (unknown), Khurram Rana, Jennifer Hammond	18
15	Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Julian Falutz, Diane Potvin, Jean‐Claude Mamputu, (unknown), (unknown), Sophie‐Élise Michaud, Daniel Berger, Michael Somero, Graeme Moyle, Stephen J. Brown, Claudia Martorell, Ralph R. Turner, Steven Grinspoon	52
16	Use of HIV Resistance Testing After Prolonged Treatment Interruption 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), (unknown), Claudia Martorell, Carol A. Rauch, Robert P. Hoffman, Daniel J. Skiest	5
17	Low Prevalence of Primary HIV Resistance in Western Massachusetts 2010 ·Journal of the International Association of Physicians in AIDS Care ·(unknown), (unknown), Claudia Martorell, Robert P. Hoffman, Daniel J. Skiest	2
18	1052 ANTIVIRAL ACTIVITY OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN FOR 28 DAYS IN TREATMENT NAIVE PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1 2009 ·Journal of Hepatology ·Ira M. Jacobson, Paul J. Pockros, Jacob Lalezari, E. Läwitz, M. Rodríguez‐Torres, E DeJesus, Felix Haas, Claudia Martorell, (unknown), (unknown), Subasree Srinivasan, (unknown), (unknown), Jennifer Hammond	32
19	High Sensitivity of Human Leukocyte Antigen–B5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients 2008 ·Clinical Infectious Diseases* ·Michael S. Saag, Rukmini Balu, Elizabeth J. Phillips, Philip S. Brachman, Claudia Martorell, William J. Burman, Britt Stancil, Michael Mosteller, Cindy Brothers, Paul Wannamaker, Arlene R. Hughes, Denise Sutherland‐Phillips, S. Mallal, Mark S. Shaefer, (unknown)	290
20	Surgical site infections in cardiac surgery: an 11-year perspective 2004 ·American Journal of Infection Control ·Claudia Martorell, Richard M. Engelman, (unknown), Richard B. Brown	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact